GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FSD Pharma Inc (NAS:HUGE) » Definitions » Other Operating Expense

FSD Pharma (FSD Pharma) Other Operating Expense : $2.51 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is FSD Pharma Other Operating Expense?

FSD Pharma's Other Operating Expense for the three months ended in Dec. 2023 was $0.12 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $2.51 Mil.

FSD Pharma's quarterly Other Operating Expense declined from Jun. 2023 ($1.11 Mil) to Sep. 2023 ($0.15 Mil) and declined from Sep. 2023 ($0.15 Mil) to Dec. 2023 ($0.12 Mil).

FSD Pharma's annual Other Operating Expense increased from Dec. 2021 ($4.05 Mil) to Dec. 2022 ($4.54 Mil) but then declined from Dec. 2022 ($4.54 Mil) to Dec. 2023 ($2.51 Mil).


FSD Pharma Other Operating Expense Historical Data

The historical data trend for FSD Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FSD Pharma Other Operating Expense Chart

FSD Pharma Annual Data
Trend Aug15 Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only 0.10 4.66 4.05 4.54 2.51

FSD Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 1.13 1.11 0.15 0.12

FSD Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FSD Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of FSD Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


FSD Pharma (FSD Pharma) Business Description

Traded in Other Exchanges
Address
199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.

FSD Pharma (FSD Pharma) Headlines

From GuruFocus